Regulation of amyloid β-peptide levels by enzymatic degradation

Journal of Alzheimer's Disease

Volumn 4, Issue 5, 2002, Pages 341-348

  Mukherjee, Atish ^a   Hersh, Louis B ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN CONVERTING ENZYME; GAMMA SECRETASE; INSULINASE; MEMBRANE METALLOENDOPEPTIDASE; PEPTIDASE; PLASMIN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; ENZYME ACTIVITY; ENZYME MECHANISM; IN VIVO STUDY; NEUROPATHOLOGY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 0036813533     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2002-4501     Document Type: Article

References (57)

1. R. Abraham, A. Myers, F. Wavrant-DeVrieze, M.L. Hamshere, H.V. Thomas, H. Marshal, D. Compton, G. Spurlock, D. Turic, B. Hoogendoorn, J.M. Kwon, R.C. Petersen, E. Tangalos, J. Norton, J.C. Morris, R. Bullock, D. Liolitsa, S. Lovestone, J. Hardy, A. Goate, M. O'Donovan, J. Williams, M.J. Owen and L. Jones, Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease, Hum Genet. 109 (2001), 646-652.
2. R. Alvarez, V. Alvarez, C.H. Lahoz, C. Martinez, J. Pena, J.M. Sanchez, L.M. Guisasola, J. Salas-Puig, G. Moris, J.A. Vidal, R. Ribacoba, B.B. Menes, D. Uria and E. Coto, Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease, J Neurol Neurosurg Psychiatry 67 (1999), 733-736.
3. J.R. Backstrom, G.P. Lim, M.J. Cullen and Z.A. Tokes, Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloidbeta peptide (1-40), J Neurosci. 16 (1996), 7910-7919.
4. J.R. Backstrom, C.A. Miller and Z.A. Tokes, Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: Identification of calcium-dependent metalloproteinases from the hippocampus, J. Neurochem. 58 (1992), 983-992.
5. R.G. Bennett, W.C. Duckworth and F.G. Hamel, Degradation of amylin by insulin-degrading enzyme, J. Biol. Chem. 275 (2000), 36621-36625.
6. L. Bertram, D. Blacker, K. Mullin, D. Keeney, J. Jones, S. Basu, S. Yhu, M.G. McInnis, R.C. Go, K. Vekrellis, D.J. Selkoe, A.J. Saunders and R.E. Tanzi, Evidence for genetic linkage of Alzheimer's disease to chromosome 10q, Science 290 (2000), 2302-2303.
7. F. Checler, The multiple paradoxs of presenilins, J. Neurochem. 76 (2001), 1621-1627.
8. V. Chesneau, K. Vekrellis, M.R. Rosner and D.J. Selkoe, Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization, Biochem. J. 351 (2000), 509-516.
9. F. Crawford, L. Abdullah, J. Schinka, Z. Suo, M. Gold, R. Duara and M. Mullan, Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease, Neurosci. Lett. 280 (2000), 215-219.
10. WC Duckworth. Insulin degradation: Mechanisms, products, and significance, Endocr Rev. 9 (1988), 319-345.
11. E.A. Eckman, D.K. Reed and C.B. Eckman, Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme, J Biol Chem. 276 (2001), 24540-24548.
12. N. Ertekin-Taner, N. Graff-Radford, L.H. Younkin, C. Eckman, M. Baker, J. Adamson, J. Ronald, J. Blangero, M. Hutton and S.G. Younkin, Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees, Science 290 (2000), 2303-2304.
13. L.A. Farrer, T. Sherbatich, S.A. Keryanov, G.I. Korovaitseva, E.A. Rogaeva, S. Petruk, S. Premkumar, Y. Moliaka, Y.Q. Song, Y. Pei, C. Sato, N.D. Selezneva, S. Voskresenskaya, V. Golimbet, S. Sorbi, R. Duara, S. Gavrilova, P.H. St George-Hyslop and E.I. Rogaev, Association between angiotensin-converting enzyme and Alzheimer disease, Arch Neurol. 57 (2000), 210-214.
14. J.V. Garcia, B.D. Gehm and M.R. Rosner, An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin, J. Cell Biol. 109 (1989), 1301-1307.
15. B.D. Gehm and M.R. Rosner, Regulation of insulin, epidermal growth factor, and transforming growth factor-alpha levels by growth factor-degrading enzymes, Endocrinology 128 (1991), 1603-1610.
16. S. Howell, J. Nalbantogluand and P. Crine, Neutral endopeptidase can hydrolyze beta-amyloid(1-40) but shows no effect on beta-amyloid precursor protein metabolism, Peptides 16 (1995), 647-652.
17. J. Hu, A. Igarashi, M. Kamata and H. Nakagawa, Angiotensin-converting enzyme degrades Alzheimer amyloid beta-Peptide (Aβ); retards Aβ aggregation, deposition, fibril formation; and inhibits cytotoxicity, J. Biol. Chem. 276 (2001), 47863-47868.
18. J. Hu, F. Miyatake, Y. Aizu, H. Nakagawa, S. Nakamura, A. Tamaoka, R. Takahash, K. Urakami and M. Shoji, Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population, Neurosci Lett. 277 (1999), 65-67.
19. N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N.P Gerard, C. Gerard, E. Hama, H.J. Lee and T.C. Saido, Metabolic regulation of brain Abeta by neprilysin, Science 292 (2001), 1550-1552.
20. N. Iwata, S. Tsubuki, Y. Takaki, K. Watanabe, M. Sekiguchi, E. Hosoki, M. Kawashima-Morishima, H.J. Lee, E. Hama, Y. Sekine-Aizawa and T.C. Saido, Identification of the major Abetal-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition, Nat. Med. 6 (2000), 143-150.
21. PG. Kehoe, C. Russ, S. McIlory, H. Williams, P. Holmans, C. Holmes, D. Liolitsa, D. Vahidassr, J. Powell, B. McGleenon, M. Liddell, R. Plomin, K. Dynan, N. Williams, J. Neal, N.J. Cairns, G. Wilcock, P. Passmore, S. Lovestone, J. Williams and M.J. Owen, Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease, Nat. Genet. 21 (1999), 71-72.
22. A.J. Kenny, Regulatory peptide metabolism at cell surfaces: The key role of endopeptidase-24.11, Biomed Biochim Acta. 45 (1986), 1503-1513.
23. I.B. Kingston, M.J. Castro and S. Anderson, In vitro stimulation of tissue-type plasminogen activator by alzheimer amyloid beta-peptide analogues, Nat. Med 1 (1995), 138-142.
24. R.J. Kirschner and A.L. Goldberg, A high molecular weight metalloendoprotease from the cytosol of mammalian cells, J. Biol. Chem. 258 (1983), 967-976.
25. I.V. Kurochkin and S. Goto, Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme, FEBS Lett. 345 (1994), 33-37.
26. C. Li and L.B. Hersh, Neprilysin: Assay methods, purification, and characterization, Methods Enzymol. 248 (1995), 253-263.
27. R. Matsas, A.J. Kenny and A.J. Turner, An immunohistochemical study of endopeptidase-24.11 ("enkephalinase") in the pig nervous system, Neuroscience 18 (1986), 91-1012.
28. J.R. McDermott and A.M. Gibson, Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: Involvement of insulin-degrading enzyme, Neurochem. Res. 22 (1997), 49-56.
29. A. Mukherjee, E. Song, M. Kihiko-Ehmann, J.P. Goodman Jr, J.S. Pyrek, S. Estus and L.B. Hersh, Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques, J. Neurosci. 20 (2000), 8745-8749.
30. D. Muller, H. Baumeister, F. Buck and D. Richter, Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme, Eur. J. Biochem. 202 (1991), 285-292.
31. D. Muller, C. Schulze, H. Baumeister, E Buck and D. Richter, Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP, and CNP revealed by HPLC and mass spectrometry, Biochemistry 31 (1992), 11138-11143.
32. A. Myers, P. Holmans, H. Marshall, J. Kwon, D. Meyer, D. Ramic, S. Shears, J. Booth, EW. DeVrieze, R. Crook, M. Hamshere, R. Abraham, N. Tunstall, F. Rice, S. Carty, S. Lillystone, P. Kehoe, V. Rudrasingham, L. Jones, S. Lovestone, J. Perez-Tur, J. Williams, M.J. Owen, J. Hardy and A.M. Goate, Susceptibility locus for Alzheimer's disease on chromosome 10, Science 290 (2000), 2304-2305.
33. Y. Narain, A. Yip, T. Murphy, C. Brayne, D. Easton, J.G. Evans, J. Xuereb, N. Cairns, M.M. Esiri, R.A. Furlong and D.C. Rubinsztein, The ACE gene and Alzheimer's disease susceptibility, J. Med. Genet. 37 (2000), 695-697.
34. J. Nunan and D.H. Small, Regulation of APP cleavage by α-, β-, and γ-secretases, FEBS Lett. 483 (2000), 6-10.
35. B. Palumbo, D. Cadini, G. Nocentini, E. Filipponi, M.L. Fravolini and U. Senin, Angiotensin converting enzyme deletion allele in different kinds of dementia disorders, Neurosci Lett. 267 (1999), 97-100.
36. A. Perez, L. Morelli, J.C. Cresto and E.M. Castano, Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains, Neurochem. Res. 25 (2000), 247-255.
37. W.Q. Qiu, W. Borth, Z. Ye, C. Haass, D.B Teplow and D.J. Selkoe, Degradation of amyloid beta-protein by a serine protease-alpha2-macroglobulin complex, J. Biol. Chem. 271 (1996), 8443-8451.
38. W.Q. Qiu, D.M. Walsh, Z. Ye, K. Vekrellis, J. Zhang, M.B. Podlisny, M.R. Rosner, A. Safavi, L.B. Hersh and D.J. Selkoe, Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation, J. Biol. Chem. 273 (1998), 32730-32738.
39. W.Q. Qiu, Z. Ye, D. Kholodenko, P. Seubert and D.J. Selkoe, Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells, J. Biol. Chem. 272 (1997), 6641-6646.
40. A. Safavi, B.C. Miller, L. Cottam and L.B. Hersh, Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme, Biochemistry 35 (1996), 14318-14325.
41. D.J. Selkoe, Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease, Annu Rev Cell Biol. 10 (1994), 373-403.
42. D.J. Selkoe, Clearing the brain's amyloid cobwebs, Neuron. 32 (2001), 177-180.
43. K.A. Seta and R.A. Roth, Overexpression of insulin degrading enzyme: Cellular localization and effects on insulin signaling, Biochem. Biophys. Res. Commun. 231 (1997), 167-171.
44. K. Shirotani, S. Tsubuki, N. Iwata, Y. Takaki, W. Harigaya, K. Maruyama, S. Kiryu-Seo, H. Kiyama, H. Iwata, T. Tomita, T. Iwatsubo and T.C. Saido, Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases, J Biol Chem. 276 (2001), 1895-21901.
45. D.H. Small, The role of presenilins in γ-secretase activity: Catalyst or cofactor? J. Neurochem. 76 (2001), 1612-1614.
46. Y. Takaki, N. lwata, S. Tsubuki, S. Taniguchi, S. Toyoshima, B. Lu, N.P. Gerard, C. Gerard, H.J. Lee, K. Shirotani and TC. Saido, Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid beta peptide in the brain, J Biochem (Tokyo) 128 (2000), 897-902.
47. H.M. Tucker, M. Kihiko, J.N. Caldwell, S. Wright, T. Kawarabayashi, D. Price, D. Walker, S. Scheff, J.P. McGillis, R.E. Rydel and S. Estus, The plasmin system is induced by and degrades amyloid-beta aggregates, J. Neurosci. 20 (2000), 3937-3946.
48. H.M. Tucker, M. Kihiko-Ehmann, S. Wright, R.E. Rydel and S. Estus, Tissue plasminogen activator requires plasminogen to modulate amyloid-beta neurotoxicity and deposition, J. Neurochem. 75 (2000), 2172-2177.
49. A.J. Turner and L.J. Murphy, Molecular pharmacology of endothelin converting enzymes, Biochem. Pharmacol 51 (1996), 91-102.
50. W.E. Van Nostrand and M. Porter, Plasmin Cleavage of the Amyloid β-Protein: Alteration of secondary Structure and Stimulation of tissue Plasminogen Activator Activity, Biochemistry 38 (1999), 11570-11575.
51. K. Vekrellis, Z. Ye, W.Q. Qiu, D. Walsh, D. Hartley, V. Chesneau, M.R. Rosner and D.J. Selkoe, Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme, J. Neurosci. 20 (2000), 1657-1665.
52. M.S. Wolfe, Presenilin and γ-secretase: Structure meets function, J. Neurochem. 76 (2001), 1615-1620.
53. M.S. Wolfe, Secretase as a target for Alzheimer's disease, Curr Top Med Chem. 2 (2002), 371-383.
54. R. Yamin, E.G. Malgeri, J.A. Sloane, W.T. McGraw and C.R. Abraham, Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-beta peptide degradation, J. Biol. Chem. 274 (1999), 18777-18784.
55. J.D. Yang, G. Feng, J. Zhang, Z.X. Lin, T. Shen, G. Breen, D. St Clair and L. He. Association between angiotensin-converting enzyme gene and late onset Alzheimer's disease in Han Chinese, Neurosci. Lett. 295 (2000), 41-44.
56. K. Yasojima, H. Akiyama, E.G. McGeer and P.L. McGeer, Reduced neprilysin in high plaque areas of Alzheimer brain: A possible relationship to deficient degradation of beta-amyloid peptide, Neurosci. Lett. 297 (2001), 97-100.
57. K. Yasojima, E.G. McGeer and P.L. McGeer, Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain, Brain Res. 919 (2001), 115-121.